Bevacizumab and deep vein thrombosis Patient Reports February 10, 2012

Bevacizumab Side Effects Report #5709286-4
Bevacizumab side effect was reported by a Health Professional from UNITED STATES on Apr 10, 2008. Male patient, weighting 137.2 lb, was diagnosed with renal cell carcinoma and was treated with Bevacizumab. After drug was administered, patient experienced the following side effects: deep vein thrombosis , renal failure, renal failure acute. Bevacizumab dosage: 15 MG/KG, Q2W. During the same period patient was treated with ADVIL, CELEBREX, CLONAZEPAM, DIOVAN, HYDRALAZINE, LORATADINE, OXYCODONE, TRICOR. Patient was hospitalized. Patient recovered.

Bevacizumab Side Effects Report #5987747-0
Bevacizumab side effect was reported by a Physician from UNITED KINGDOM on Nov 24, 2008. Female patient was diagnosed with renal cell carcinoma and was treated with Bevacizumab. After drug was administered, patient experienced the following side effects: deep vein thrombosis , hyperglycaemia, ketosis, oropharyngeal pain, pulmonary embolism , retching. Bevacizumab dosage: 620 MG, 2/WEEK. During the same period patient was treated with TEMSIROLIMUS. Patient recovered.

Bevacizumab Side Effects Report #5992815-3
Bevacizumab side effect was reported by a Consumer or non-health professional from UNITED STATES on Nov 26, 2008. Female patient was diagnosed with renal cell carcinoma and was treated with Bevacizumab. After drug was administered, patient experienced the following side effects: deep vein thrombosis , hyperglycaemia, ketosis, pulmonary embolism . Bevacizumab dosage: 620 MG, 2/WEEK. During the same period patient was treated with TEMSIROLIMUS, DOMPERIDONE, CEFOTAXIME, HEPARIN, GLIMEPIRIDE, METFORMIN, ACTRAPID, WARFARIN. Patient was hospitalized. Patient recovered.

Bevacizumab Side Effects Report #6012466-4
Bevacizumab side effect was reported by a Consumer or non-health professional from UNITED STATES on Dec 03, 2008. Female patient was diagnosed with renal cell carcinoma and was treated with Bevacizumab. After drug was administered, patient experienced the following side effects: deep vein thrombosis , hyperglycaemia, ketosis, pulmonary embolism . Bevacizumab dosage: 620 MG, 2/WEEK. During the same period patient was treated with TEMSIROLIMUS, DOMPERIDONE, CEFOTAXIME, HEPARIN, GLIMEPIRIDE, METFORMIN, ACTRAPID, WARFARIN. Patient was hospitalized. Patient recovered.


Bevacizumab Side Effects Report #6027898-8
Bevacizumab side effect was reported by a Consumer or non-health professional from UNITED STATES on Dec 22, 2008. Female patient was diagnosed with renal cell carcinoma and was treated with Bevacizumab. After drug was administered, patient experienced the following side effects: atelectasis, deep vein thrombosis , dermatitis acneiform, dysuria, electrocardiogram st-t change, hyperglycaemia, inflammation, ketosis, oropharyngeal pain. Bevacizumab dosage: 620 MG, 2/WEEK. During the same period patient was treated with TEMSIROLIMUS, DOMPERIDONE, CEFOTAXIME, HEPARIN, GLIMEPIRIDE, METFORMIN, ACTRAPID, WARFARIN. Patient was hospitalized. Patient recovered.

Bevacizumab Side Effects Report #6039336-X
Bevacizumab side effect was reported by a Consumer or non-health professional from UNITED STATES on Dec 31, 2008. Female patient was diagnosed with renal cell carcinoma and was treated with Bevacizumab. After drug was administered, patient experienced the following side effects: deep vein thrombosis , diabetes mellitus, ketosis, pulmonary embolism . Bevacizumab dosage: 620 MG, 2/WEEK. During the same period patient was treated with TEMSIROLIMUS, DOMPERIDONE, CEFOTAXIME, HEPARIN, GLIMEPIRIDE, METFORMIN, ACTRAPID, WARFARIN. Patient was hospitalized. Patient recovered.

Bevacizumab Side Effects Report #6098791-X
Bevacizumab side effect was reported by a Consumer or non-health professional from UNITED STATES on Feb 16, 2009. Female patient was diagnosed with renal cell carcinoma and was treated with Bevacizumab. After drug was administered, patient experienced the following side effects: deep vein thrombosis , diabetes mellitus, ketosis, pulmonary embolism . Bevacizumab dosage: 620 MG, 2/WEEK. During the same period patient was treated with TEMSIROLIMUS, DOMPERIDONE, CEFOTAXIME, HEPARIN, GLIMEPIRIDE, METFORMIN, ACTRAPID, WARFARIN. Patient was hospitalized. Patient recovered.

Bevacizumab Side Effects Report #5127392-2
Bevacizumab side effect was reported by a Health Professional from UNITED STATES on Oct 13, 2006. Male patient, weighting 213.4 lb, was diagnosed with rectal cancer metastatic and was treated with Bevacizumab. After drug was administered, patient experienced the following side effects: deep vein thrombosis , pulmonary embolism . Bevacizumab dosage: 5MG/KG Q 2 WEEKS IV DRIP. Patient was hospitalized. Patient recovered.

Bevacizumab Side Effects Report #4928905-3
Bevacizumab side effect was reported by a Health Professional from UNITED STATES on Feb 28, 2006. Female patient, 56 years of age, was diagnosed with rectal cancer and was treated with Bevacizumab. After drug was administered, patient experienced the following side effects: cholecystitis acute, deep vein thrombosis . Bevacizumab dosage: 566 MG Q 2 WEEKS IV. During the same period patient was treated with OXALIPLATIN, FLUOROURACIL, ATENOLOL, LASIX, ALBUTEROL. Patient was hospitalized. Patient recovered.


Bevacizumab Side Effects Report #4932736-8
Bevacizumab side effect was reported by a Health Professional from UNITED STATES on Mar 01, 2006. Female patient, 56 years of age, was diagnosed with rectal cancer and was treated with Bevacizumab. After drug was administered, patient experienced the following side effects: cholecystitis acute, deep vein thrombosis . Bevacizumab dosage: 566 MG Q 2 WEEKS. During the same period patient was treated with OXALIPLATIN, FLUOROURACIL, ATENOLOL, LASIX, ALBUTEROL. Patient was hospitalized. Patient recovered.

Bevacizumab Side Effects Report #5650471-8
Bevacizumab side effect was reported by a Health Professional from UNITED STATES on Mar 04, 2008. Female patient, weighting 250.0 lb, was diagnosed with rectal cancer and was treated with Bevacizumab. After drug was administered, patient experienced the following side effects: deep vein thrombosis , embolism. Bevacizumab dosage: 5MG/KG Q14 DAYSIV. During the same period patient was treated with OXALIPLATIN. Patient was hospitalized. Patient recovered.

Bevacizumab Side Effects Report #5986009-5
Bevacizumab side effect was reported by a Health Professional from UNITED STATES on Dec 05, 2008. Male patient, 68 years of age, weighting 222.7 lb, was diagnosed with pancreatic carcinoma metastatic and was treated with Bevacizumab. After drug was administered, patient experienced the following side effects: deep vein thrombosis , pleural effusion, pulmonary embolism . Bevacizumab dosage: 1010MG Q2WKS IV. During the same period patient was treated with GEMCITABINE, DOCETAXEL. Patient was hospitalized and became disabled. Patient recovered.

Bevacizumab Side Effects Report #6011680-1
Bevacizumab side effect was reported by a Health Professional from UNITED STATES on Dec 17, 2008. Male patient, 68 years of age, weighting 222.7 lb, was diagnosed with pancreatic carcinoma metastatic and was treated with Bevacizumab. After drug was administered, patient experienced the following side effects: decubitus ulcer, deep vein thrombosis , dyspnoea, oedema peripheral, pleural effusion, pulmonary embolism , white blood cell count decreased. Bevacizumab dosage: 1010MG Q2WKS IV. During the same period patient was treated with GEMCITABINE, DOCETAXEL. Patient was hospitalized. Patient recovered.

Bevacizumab Side Effects Report #6109467-4
Bevacizumab side effect was reported by a Health Professional from UNITED STATES on Mar 06, 2009. Male patient, 67 years of age, weighting 190.0 lb, was diagnosed with pancreatic carcinoma metastatic and was treated with Bevacizumab. After drug was administered, patient experienced the following side effects: abdominal distension, deep vein thrombosis , gastric disorder, gastrointestinal disorder, hepatic lesion, hiccups, intestinal fistula, nausea , neoplasm progression. Bevacizumab dosage: 10MG/KG IV, D1+15 28DAY. During the same period patient was treated with GEMCITABINE, FLUOROURACIL, AMBIEN, ATENOL, ATIVAN, AVANDARYL, DARVOCET, LANTUS. Patient was hospitalized. Patient recovered.


Bevacizumab Side Effects Report #6109485-6
Bevacizumab side effect was reported by a Health Professional from UNITED STATES on Mar 06, 2009. Male patient, 67 years of age, weighting 190.0 lb, was diagnosed with pancreatic carcinoma metastatic and was treated with Bevacizumab. After drug was administered, patient experienced the following side effects: abdominal distension, deep vein thrombosis , gastric disorder, gastrointestinal disorder, hepatic lesion, hiccups, intestinal fistula, nausea , neoplasm progression. Bevacizumab dosage: 10MG/KGIV, D1+15 28 DAY. During the same period patient was treated with GEMCITABINE, FLUOROURACIL, AMBIAN PRN, ATENOL, ATIVAN PRN, AVANDARYL, DARVOCET, LANTUS. Patient was hospitalized. Patient recovered.

Bevacizumab Side Effects Report #5910477-8
Bevacizumab side effect was reported by a Health Professional from UNITED STATES on Oct 06, 2008. Male patient, 61 years of age, weighting 150.3 lb, was diagnosed with pancreatic carcinoma metastatic and was treated with Bevacizumab. After drug was administered, patient experienced the following side effects: colitis, deep vein thrombosis , gastrointestinal haemorrhage. Bevacizumab dosage: 10MG/KGIV,D1+15 OF CYCL. During the same period patient was treated with COMPAZINE, CREON, METHATDONE, MIRALAX, VICODIN. Patient was hospitalized. Patient recovered.

Bevacizumab Side Effects Report #5272635-8
Bevacizumab side effect was reported by a Health Professional from UNITED STATES on Mar 20, 2007. Female patient, weighting 136.0 lb, was diagnosed with pancreatic carcinoma metastatic and was treated with Bevacizumab. After drug was administered, patient experienced the following side effects: deep vein thrombosis , pulmonary embolism . Bevacizumab dosage: 15MG/KG EVERY 3 WEEKS IV DRIP. During the same period patient was treated with ERLOTINIB. Patient was hospitalized. Patient recovered.

Bevacizumab Side Effects Report #6092356-1
Bevacizumab side effect was reported by a Health Professional from UNITED STATES on Feb 23, 2009. Male patient, weighting 201.0 lb, was diagnosed with pancreatic carcinoma metastatic and was treated with Bevacizumab. After drug was administered, patient experienced the following side effects: deep vein thrombosis , disease progression, nausea . Bevacizumab dosage: 15MG/KG, 1370 MG EVERY 3 WEEKS IV. During the same period patient was treated with ERLOTINIB. Patient was hospitalized. Patient recovered.

Bevacizumab Side Effects Report #5745905-4
Bevacizumab side effect was reported by a Pharmacist from UNITED STATES on May 13, 2008. Male patient was diagnosed with oesophageal adenocarcinoma and was treated with Bevacizumab. After drug was administered, patient experienced the following side effects: deep vein thrombosis , dehydration, hypocalcaemia, hypokalaemia, hypomagnesaemia, neutropenia, nodule, oesophageal ulcer, oesophagitis. Bevacizumab dosage: unknown. During the same period patient was treated with CISPLATIN, IRINOTECAN. Patient was hospitalized. Patient recovered.


Bevacizumab Side Effects Report #5300838-2
Bevacizumab side effect was reported by a Consumer or non-health professional from UNITED STATES on Apr 17, 2007. Male patient, 75 years of age, weighting 196.2 lb, was diagnosed with non-small cell lung cancer, bone marrow failure and was treated with Bevacizumab. After drug was administered, patient experienced the following side effects: asthenia, cough, decubitus ulcer, deep vein thrombosis , diarrhoea, haemoglobin decreased, hyperhidrosis, lung infiltration, oxygen saturation decreased. Bevacizumab dosage: 15 MG/KG, Q3W. During the same period patient was treated with TAXOTERE, OXALIPLATIN, DILAUDID, FILGRASTIM, DURAGESIC, TUSSINEX, PHENERGAN, HYCODAN. Patient was hospitalized. Patient recovered.

Bevacizumab Side Effects Report #5354616-9
Bevacizumab side effect was reported by a Physician from UNITED STATES on June 06, 2007. Male patient, 75 years of age, weighting 196.2 lb, was diagnosed with non-small cell lung cancer, bone marrow failure and was treated with Bevacizumab. After drug was administered, patient experienced the following side effects: decubitus ulcer, deep vein thrombosis , pyrexia. Bevacizumab dosage: 15 MG/KG, Q3W. During the same period patient was treated with TAXOTERE, OXALIPLATIN, DILAUDID, FILGRASTIM, DURAGESIC, TUSSINEX, PHENERGAN, HYCODAN. Patient was hospitalized. Patient recovered.

Bevacizumab Side Effects Report #5143468-8
Bevacizumab side effect was reported by a Physician from UNITED STATES on Nov 01, 2006. Male patient, 68 years of age, weighting 188.5 lb, was diagnosed with non-small cell lung cancer and was treated with Bevacizumab. After drug was administered, patient experienced the following side effects: deep vein thrombosis , pulmonary embolism , radiation oesophagitis. Bevacizumab dosage: 15MG/KG, Q3WEEKS, IV. During the same period patient was treated with PACLITAXEL, CARBOPLATIN. Patient was hospitalized. Patient recovered.

Bevacizumab Side Effects Report #5370535-6
Bevacizumab side effect was reported by a Physician from UNITED STATES on June 21, 2007. Female patient, 48 years of age, weighting 118.2 lb, was diagnosed with non-small cell lung cancer and was treated with Bevacizumab. After drug was administered, patient experienced the following side effects: atrial fibrillation , deep vein thrombosis . Bevacizumab dosage: 15 MG/KG, Q3W. During the same period patient was treated with GEMCITABINE, PROCHLORPERAZINE, PREDNISONE, DIOVAN, HYDROMORPHONE, INSULIN GLARGINE, INSULIN LISPRO, CHLORTHIAZIDE. Patient was hospitalized. Patient recovered.

Bevacizumab Side Effects Report #5586042-1
Bevacizumab side effect was reported by a Physician from UNITED STATES on Jan 03, 2008. Female patient, 48 years of age, weighting 118.2 lb, was diagnosed with non-small cell lung cancer and was treated with Bevacizumab. After drug was administered, patient experienced the following side effects: atrial fibrillation , deep vein thrombosis . Bevacizumab dosage: 15 MG/KG, Q3W. During the same period patient was treated with GEMCITABINE, PROCHLORPERAZINE, PREDNISONE, DIOVAN, HYDROMORPHONE, INSULIN GLARGINE, INSULIN LISPRO, CHLORTHIAZIDE. Patient was hospitalized. Patient recovered.


Bevacizumab Side Effects Report #5868154-8
Bevacizumab side effect was reported by a Physician from UNITED STATES on Aug 25, 2008. Female patient, 48 years of age, weighting 118.2 lb, was diagnosed with non-small cell lung cancer and was treated with Bevacizumab. After drug was administered, patient experienced the following side effects: atrial fibrillation , deep vein thrombosis . Bevacizumab dosage: 15 MG/KG, Q3W. During the same period patient was treated with GEMCITABINE, PROCHLORPERAZINE, PREDNISONE, DIOVAN, HYDROMORPHONE, LANTUS, INSULIN LISPRO, CHLORTHIAZIDE. Patient was hospitalized. Patient recovered.

Bevacizumab Side Effects Report #6039223-7
Bevacizumab side effect was reported by a Physician from UNITED STATES on Jan 08, 2009. Female patient, 48 years of age, weighting 118.2 lb, was diagnosed with non-small cell lung cancer and was treated with Bevacizumab. After drug was administered, patient experienced the following side effects: atrial fibrillation , deep vein thrombosis , pneumonia , vomiting. Bevacizumab dosage: 15 MG/KG, Q3W. During the same period patient was treated with GEMCITABINE, DOCETAXEL, PROCHLORPERAZINE, PREDNISONE, DIOVAN, HYDROMORPHONE, INSULIN GLARGINE, INSULIN LISPRO. Patient was hospitalized. Patient died on 04/08/2007.

Bevacizumab Side Effects Report #6075890-X
Bevacizumab side effect was reported by a Physician from UNITED STATES on Feb 05, 2009. Female patient, 48 years of age, weighting 118.2 lb, was diagnosed with non-small cell lung cancer and was treated with Bevacizumab. After drug was administered, patient experienced the following side effects: atrial fibrillation , deep vein thrombosis , pneumonia , vomiting. Bevacizumab dosage: 15 MG/KG, Q3W. During the same period patient was treated with GEMCITABINE, DOCETAXEL, PROCHLORPERAZINE, PREDNISONE, DIOVAN, HYDROMORPHONE, INSULIN GLARGINE, INSULIN LISPRO. Patient was hospitalized. Patient recovered.

Bevacizumab Side Effects Report #6016256-8
Bevacizumab side effect was reported by a Physician from SLOVAKIA (Slovak Republic) on Dec 12, 2008. Male patient, weighting 167.6 lb, was diagnosed with metastatic renal cell carcinoma and was treated with Bevacizumab. After drug was administered, patient experienced the following side effects: deep vein thrombosis . Bevacizumab dosage: unknown. During the same period patient was treated with INTERFERON ALFA. Patient was hospitalized. Patient recovered.

Bevacizumab Side Effects Report #6017329-6
Bevacizumab side effect was reported by a Physician from SLOVAKIA (Slovak Republic) on Dec 19, 2008. Male patient, weighting 167.6 lb, was diagnosed with metastatic renal cell carcinoma and was treated with Bevacizumab. After drug was administered, patient experienced the following side effects: deep vein thrombosis , pulmonary embolism . Bevacizumab dosage: unknown. During the same period patient was treated with INTERFERON ALFA. Patient was hospitalized. Patient recovered.


Bevacizumab Side Effects Report #6019231-2
Bevacizumab side effect was reported by a Physician from SLOVAKIA (Slovak Republic) on Dec 24, 2008. Male patient, weighting 167.6 lb, was diagnosed with metastatic renal cell carcinoma and was treated with Bevacizumab. After drug was administered, patient experienced the following side effects: deep vein thrombosis , pulmonary embolism . Bevacizumab dosage: unknown. During the same period patient was treated with INTERFERON ALFA. Patient was hospitalized. Patient recovered.

Bevacizumab Side Effects Report #6052069-9
Bevacizumab side effect was reported by a Physician from SLOVAKIA (Slovak Republic) on Jan 15, 2009. Male patient, weighting 172.0 lb, was diagnosed with metastatic renal cell carcinoma and was treated with Bevacizumab. After drug was administered, patient experienced the following side effects: deep vein thrombosis , pulmonary embolism . Bevacizumab dosage: unknown. During the same period patient was treated with INTERFERON ALFA. Patient was hospitalized. Patient recovered.

Bevacizumab Side Effects Report #5977620-6
Bevacizumab side effect was reported by a Health Professional from UNITED STATES on Dec 01, 2008. Female patient, 39 years of age, weighting 138.0 lb, was diagnosed with metastatic gastric cancer and was treated with Bevacizumab. After drug was administered, patient experienced the following side effects: deep vein thrombosis , oedema peripheral, pain in extremity, thyroid mass. Bevacizumab dosage: 7.5 MG/KG D1/22DAY CYCLE. During the same period patient was treated with OXALIPLATIN, DOCETAXEL, AMBIEN, ATIVAN, COMPAZINE, DECADRON, LOVENOX, OXYCODONE. Patient was hospitalized. Patient recovered.

Bevacizumab Side Effects Report #5521634-7
Bevacizumab side effect was reported by a Pharmacist from UNITED STATES on Nov 19, 2007. Male patient, 85 years of age, was diagnosed with lymphoma  and was treated with Bevacizumab. After drug was administered, patient experienced the following side effects: deep vein thrombosis , thrombocytopenia. Bevacizumab dosage: 1027 MG UD IV. Patient was hospitalized. Patient recovered.

Bevacizumab Side Effects Report #5387772-7
Bevacizumab side effect was reported by a Consumer or non-health professional from UNITED STATES on July 12, 2007. Male patient, 68 years of age, weighting 222.7 lb, was diagnosed with glioblastoma multiforme and was treated with Bevacizumab. After drug was administered, patient experienced the following side effects: deep vein thrombosis , headache , lung infection, pulmonary embolism , pulmonary infarction, pyrexia. Bevacizumab dosage: 10 MG/KG. During the same period patient was treated with ERLOTINIB, KEPPRA, ZOFRAN, LEXAPRO, DECADRON, PRILOSEC, REGLAN. Patient was hospitalized. Patient recovered.


Bevacizumab Side Effects Report #5229515-3
Bevacizumab side effect was reported by a Physician from UNITED STATES on Jan 19, 2007. Male patient, 60 years of age, weighting 225.1 lb, was diagnosed with glioblastoma multiforme and was treated with Bevacizumab. After drug was administered, patient experienced the following side effects: abnormal behaviour, computerised tomogram abnormal, deep vein thrombosis , hydrocephalus , pulmonary embolism . Bevacizumab dosage: unknown. During the same period patient was treated with IRINOTECAN. Patient was hospitalized. Patient recovered.

Bevacizumab Side Effects Report #5287046-9
Bevacizumab side effect was reported by a Physician from UNITED STATES on Mar 23, 2007. Male patient, 60 years of age, weighting 225.1 lb, was diagnosed with glioblastoma multiforme and was treated with Bevacizumab. After drug was administered, patient experienced the following side effects: abnormal behaviour, deep vein thrombosis , hydrocephalus , neutrophil count decreased, pneumonia , pulmonary embolism , urinary tract infection . Bevacizumab dosage: unknown. During the same period patient was treated with IRINOTECAN, LEVAQUIN, THIAMINE HYDROCHLORIDE, DEXAMETHASONE, HEPARIN. Patient was hospitalized. Patient recovered.

Bevacizumab Side Effects Report #5904015-3
Bevacizumab side effect was reported by a Physician from UNITED KINGDOM on Sept 15, 2008. Female patient, 60 years of age, was diagnosed with glioblastoma multiforme and was treated with Bevacizumab. After drug was administered, patient experienced the following side effects: convulsion, deep vein thrombosis , hypertension, pulmonary embolism . Bevacizumab dosage: 10 MG/KG, Q2W. During the same period patient was treated with TEMOZOLOMIDE. Patient was hospitalized. Patient recovered.

Bevacizumab Side Effects Report #5903803-7
Bevacizumab side effect was reported by a Consumer or non-health professional from UNITED KINGDOM on Sept 15, 2008. Female patient, 46 years of age, was diagnosed with glioblastoma multiforme and was treated with Bevacizumab. After drug was administered, patient experienced the following side effects: deep vein thrombosis , infection , intracranial hypotension, pulmonary embolism , wound decomposition. Bevacizumab dosage: 10 MG/KG, Q2W. During the same period patient was treated with TEMOZOLOMIDE. Patient recovered.

Bevacizumab Side Effects Report #5373567-7
Bevacizumab side effect was reported by a Health Professional from UNITED STATES on June 26, 2007. Female patient, 32 years of age, was diagnosed with glioblastoma multiforme and was treated with Bevacizumab. After drug was administered, patient experienced the following side effects: deep vein thrombosis , fall , skin ulcer. Bevacizumab dosage: unknown. During the same period patient was treated with ETOPOSIDE, KEPPRA, COLACE, DECADRON, FIBER. Patient was hospitalized. Patient recovered.


Bevacizumab Side Effects Report #5381162-9
Bevacizumab side effect was reported by a Health Professional from UNITED STATES on June 25, 2007. Female patient was diagnosed with glioblastoma multiforme and was treated with Bevacizumab. After drug was administered, patient experienced the following side effects: deep vein thrombosis , fall , skin ulcer. Bevacizumab dosage: 10 MG/KG, DAYS 1+15. During the same period patient was treated with ETOPOSIDE, KEPPRA, COLACE, DECADRON, FIBER. Patient was hospitalized. Patient recovered.

Bevacizumab Side Effects Report #5401461-1
Bevacizumab side effect was reported by a Health Professional from UNITED STATES on July 20, 2007. Female patient was diagnosed with glioblastoma multiforme and was treated with Bevacizumab. After drug was administered, patient experienced the following side effects: deep vein thrombosis , fall , skin ulcer. Bevacizumab dosage: 10 MG/KG, DAYS 1+15. During the same period patient was treated with ETOPOSIDE, KEPPRA, COLACE, DECADRON, FIBER. Patient was hospitalized. Patient recovered.

Bevacizumab Side Effects Report #5445550-4
Bevacizumab side effect was reported by a Health Professional from UNITED STATES on Sept 05, 2007. Female patient was diagnosed with glioblastoma multiforme and was treated with Bevacizumab. After drug was administered, patient experienced the following side effects: deep vein thrombosis , fall , skin ulcer. Bevacizumab dosage: 10 MG/KG, DAYS 1+15. During the same period patient was treated with ETOPOSIDE, KEPPRA, COLACE, DECADRON, FIBER. Patient was hospitalized. Patient recovered.

Bevacizumab Side Effects Report #5463066-6
Bevacizumab side effect was reported by a Consumer or non-health professional from UNITED STATES on Sept 18, 2007. Male patient was diagnosed with glioblastoma multiforme and was treated with Bevacizumab. After drug was administered, patient experienced the following side effects: abdominal distension, atelectasis, convulsion, deep vein thrombosis , impaired gastric emptying. Bevacizumab dosage: 10 MG/KG. During the same period patient was treated with ERLOTINIB, DEXAMETHASONE, LUNESTA, TYLENOL, POTASSIUM CHLORIDE, LASIX, VYTORIN, TOPROL. Patient was hospitalized. Patient recovered.

Bevacizumab Side Effects Report #5636015-5
Bevacizumab side effect was reported by a Health Professional from UNITED STATES on Feb 20, 2008. Male patient, weighting 185.2 lb, was diagnosed with glioblastoma multiforme and was treated with Bevacizumab. After drug was administered, patient experienced the following side effects: deep vein thrombosis , haematochezia, hyperglycaemia, pulmonary embolism . Bevacizumab dosage: 10 MG/KG, IV Q2WKS. During the same period patient was treated with TEMOZOLOMIDE, LISINOPRIL, PEPCID, DEXAMETHASONE, FLONASE. Patient was hospitalized. Patient recovered.

Bevacizumab Side Effects Report #5636602-4
Bevacizumab side effect was reported by a Health Professional from UNITED STATES on Feb 19, 2008. Male patient, weighting 185.2 lb, was diagnosed with glioblastoma multiforme and was treated with Bevacizumab. After drug was administered, patient experienced the following side effects: deep vein thrombosis , haematochezia, hyperglycaemia, pulmonary embolism . Bevacizumab dosage: 10 MG/KG, IV Q2WKS. During the same period patient was treated with TEMOZOLOMIDE, LISINOPRIL, PEPCID, DEXAMETHASONE, FLONASE. Patient was hospitalized. Patient recovered.

Bevacizumab Side Effects Report #5793183-2
Bevacizumab side effect was reported by a Health Professional from UNITED STATES on June 26, 2008. Male patient, weighting 249.1 lb, was diagnosed with glioblastoma multiforme and was treated with Bevacizumab. After drug was administered, patient experienced the following side effects: deep vein thrombosis , pulmonary embolism . Bevacizumab dosage: 1125 MG. During the same period patient was treated with TEMOZOLOMIDE, LASIX, DECADRON, NEXIUM, TYLENOL W, SPIRONOLACTONE, FLUCONAZOLE. Patient was hospitalized. Patient recovered.

Bevacizumab Side Effects Report #5596057-5
Bevacizumab side effect was reported by a Consumer or non-health professional from UNITED KINGDOM on Jan 07, 2008. Female patient was diagnosed with gastrointestinal carcinoma and was treated with Bevacizumab. After drug was administered, patient experienced the following side effects: abdominal pain , deep vein thrombosis , pyrexia. Bevacizumab dosage: 560 MG, Q2W. During the same period patient was treated with ERLOTINIB, BUPRENORPHINE HYDROCHLORIDE, PREDNISOLONE, LACTULOSE, NEXIUM, LAXOBERAL. Patient was hospitalized. Patient died on 02/25/2007.

Bevacizumab Side Effects Report #5610949-X
Bevacizumab side effect was reported by a Consumer or non-health professional from UNITED KINGDOM on Jan 30, 2008. Female patient was diagnosed with gastrointestinal carcinoma and was treated with Bevacizumab. After drug was administered, patient experienced the following side effects: abdominal pain , deep vein thrombosis , pyrexia. Bevacizumab dosage: 560 MG, Q2W. During the same period patient was treated with ERLOTINIB, BUPRENORPHINE HYDROCHLORIDE, PREDNISOLONE, LACTULOSE, NEXIUM, LAXOBERAL. Patient was hospitalized. Patient died on 02/25/2007.

Bevacizumab Side Effects Report #5610954-3
Bevacizumab side effect was reported by a Consumer or non-health professional from UNITED KINGDOM on Jan 30, 2008. Female patient was diagnosed with gastrointestinal carcinoma and was treated with Bevacizumab. After drug was administered, patient experienced the following side effects: abdominal pain , c-reactive protein increased, deep vein thrombosis , depression , disease progression, ileus, infection , pyrexia, small intestinal obstruction. Bevacizumab dosage: 560 MG, Q2W. During the same period patient was treated with ERLOTINIB, BUPRENORPHINE HYDROCHLORIDE, PREDNISOLONE, LACTULOSE, NEXIUM, LAXOBERAL. Patient was hospitalized. Patient recovered.


Bevacizumab Side Effects Report #5991105-2
Bevacizumab side effect was reported by a Physician from UNITED STATES on Dec 03, 2008. Female patient was diagnosed with endometrial cancer, pulmonary embolism  and was treated with Bevacizumab. After drug was administered, patient experienced the following side effects: deep vein thrombosis , failure to thrive, muscular weakness, pulmonary embolism . Bevacizumab dosage: 15 MG/KG, Q3W. During the same period patient was treated with COUMADIN. Patient was hospitalized. Patient recovered.

Bevacizumab Side Effects Report #6002185-2
Bevacizumab side effect was reported by a Physician from UNITED STATES on Dec 03, 2008. Female patient was diagnosed with diffuse large b-cell lymphoma and was treated with Bevacizumab. After drug was administered, patient experienced the following side effects: deep vein thrombosis . Bevacizumab dosage: 15 MG/KG, Q3W. During the same period patient was treated with RITUXIMAB, CYCLOPHOSPHAMIDE, DOXORUBICIN, VINCRISTINE, PREDNISONE, LOVENOX. Patient was hospitalized. Patient recovered.

Bevacizumab Side Effects Report #5695106-3
Bevacizumab side effect was reported by a Physician from UNITED STATES on Mar 27, 2008. Female patient, weighting 132.5 lb, was diagnosed with colorectal cancer metastatic and was treated with Bevacizumab. After drug was administered, patient experienced the following side effects: deep vein thrombosis . Bevacizumab dosage: 5 MG/KG, Q2W. During the same period patient was treated with LEUCOVORIN CALCIUM, FLUOROURACIL, OXALIPLATIN. Patient was hospitalized. Patient died on 02/14/2008.

Bevacizumab Side Effects Report #5827304-X
Bevacizumab side effect was reported by a Health Professional from UNITED STATES on July 22, 2008. Male patient, weighting 134.0 lb, was diagnosed with colorectal cancer metastatic and was treated with Bevacizumab. After drug was administered, patient experienced the following side effects: anaemia, deep vein thrombosis , gastrointestinal haemorrhage, oesophagitis, shock haemorrhagic. Bevacizumab dosage: 5 MG/KG, Q2W. During the same period patient was treated with OXALIPLATIN, FLUOROURACIL, LEUCOVORIN CALCIUM, ZOFRAN, PRILOSEC, ALTERNAGEL, LASIX. Patient was hospitalized. Patient died on 04/27/2008.

Bevacizumab Side Effects Report #6019868-0
Bevacizumab side effect was reported by a Health Professional from UNITED STATES on Dec 18, 2008. Male patient, weighting 134.0 lb, was diagnosed with colorectal cancer metastatic and was treated with Bevacizumab. After drug was administered, patient experienced the following side effects: anaemia, deep vein thrombosis , gastrointestinal haemorrhage, oesophagitis, shock haemorrhagic. Bevacizumab dosage: 5 MG/KG, Q2W. During the same period patient was treated with OXALIPLATIN, FLUOROURACIL, LEUCOVORIN CALCIUM, ZOFRAN, PRILOSEC, ALTERNAGEL, LASIX. Patient was hospitalized. Patient died on 04/27/2008.

Bevacizumab Side Effects Report #4668433-6
Bevacizumab side effect was reported by a Physician from on May 09, 2005. Female patient, 36 years of age, was diagnosed with colorectal cancer  and was treated with Bevacizumab. After drug was administered, patient experienced the following side effects: abdominal distension, abdominal mass, abdominal pain , anorexia, back pain , colorectal cancer metastatic, deep vein thrombosis , dehydration, dizziness . Bevacizumab dosage: 5 MG/KG, Q2W, INTRAVENOUS. During the same period patient was treated with CETUXIMAB. Patient was hospitalized. Patient recovered.

Bevacizumab Side Effects Report #4687994-4
Bevacizumab side effect was reported by a Consumer or non-health professional from on May 24, 2005. Female patient, 36 years of age, was diagnosed with colorectal cancer  and was treated with Bevacizumab. After drug was administered, patient experienced the following side effects: abdominal distension, abdominal mass, atelectasis, back pain , bacteria blood identified, deep vein thrombosis , dehydration, dizziness , gastric outlet obstruction. Bevacizumab dosage: 5 MG/KG, Q2WL INTRAVENOUS (SEE IMAGE). During the same period patient was treated with CETUXIMAB. Patient was hospitalized. Patient recovered.

Bevacizumab Side Effects Report #4852904-3
Bevacizumab side effect was reported by a Consumer or non-health professional from UNITED STATES on Dec 12, 2005. Female patient, weighting 124.3 lb, was diagnosed with colorectal cancer  and was treated with Bevacizumab. After drug was administered, patient experienced the following side effects: deep vein thrombosis . Bevacizumab dosage: unknown. During the same period patient was treated with NPH INSULIN, REGULAR INSULIN. Patient was hospitalized. Patient recovered.

Bevacizumab Side Effects Report #5853011-3
Bevacizumab side effect was reported by a Physician from UNITED KINGDOM on Aug 06, 2008. Female patient, weighting 123.5 lb, was diagnosed with colon cancer metastatic and was treated with Bevacizumab. After drug was administered, patient experienced the following side effects: deep vein thrombosis , pulmonary artery thrombosis. Bevacizumab dosage: 5 MG/KG, UNK. During the same period patient was treated with OXALIPLATIN, FLUOROURACIL, ISOVORIN, IRINOTECAN, LEUCOVORIN CALCIUM. Patient was hospitalized and became disabled. Patient recovered.

Bevacizumab Side Effects Report #5319454-1
Bevacizumab side effect was reported by a Physician from UNITED KINGDOM on Apr 23, 2007. Male patient was diagnosed with colon cancer and was treated with Bevacizumab. After drug was administered, patient experienced the following side effects: deep vein thrombosis , epistaxis, haematemesis, headache , oesophageal ulcer, photophobia, vomiting. Bevacizumab dosage: 575 MG, Q3W. During the same period patient was treated with CAPECITABINE, PROCHLORPERAZINE. Patient was hospitalized. Patient recovered.


Bevacizumab Side Effects Report #5325629-8
Bevacizumab side effect was reported by a Physician from UNITED KINGDOM on May 03, 2007. Male patient, weighting 170.2 lb, was diagnosed with colon cancer, infection  and was treated with Bevacizumab. After drug was administered, patient experienced the following side effects: cellulitis , deep vein thrombosis , gastric haemorrhage, haematemesis, haemoglobin decreased, infection , no therapeutic response, oesophageal ulcer, ulcer haemorrhage. Bevacizumab dosage: 575 MG, Q3W. During the same period patient was treated with CAPECITABINE, FUSIDATE, VANCOMYCIN, OMEPRAZOLE, FLUCLOXACILLINE, PARACETAMOL, VITAMIN K, IMIPENEM. Patient was hospitalized. Patient recovered.

Bevacizumab Side Effects Report #5989123-3
Bevacizumab side effect was reported by a Physician from UNITED KINGDOM on Nov 26, 2008. Female patient was diagnosed with colon cancer and was treated with Bevacizumab. After drug was administered, patient experienced the following side effects: deep vein thrombosis , mood altered, rectal haemorrhage. Bevacizumab dosage: unknown. During the same period patient was treated with CAPECITABINE, IRINOTECAN HYDROCHLORIDE. Patient was hospitalized. Patient recovered.

Bevacizumab Side Effects Report #6019776-5
Bevacizumab side effect was reported by a Physician from UNITED KINGDOM on Dec 11, 2008. Female patient was diagnosed with colon cancer and was treated with Bevacizumab. After drug was administered, patient experienced the following side effects: deep vein thrombosis . Bevacizumab dosage: 525 MG, Q3W. During the same period patient was treated with CAPECITABINE. Patient recovered.

Bevacizumab Side Effects Report #4641073-0
Bevacizumab side effect was reported by a Health Professional from on Apr 19, 2005. Female patient, 58 years of age, weighting 148.4 lb, was diagnosed with breast cancer metastatic and was treated with Bevacizumab. After drug was administered, patient experienced the following side effects: deep vein thrombosis , liver disorder, portal vein thrombosis. Bevacizumab dosage: 10 MG/KG DAYS 1 AND 15 INTRAVENOU. Patient recovered.

Bevacizumab Side Effects Report #5547342-4
Bevacizumab side effect was reported by a Physician from UNITED STATES on Dec 03, 2007. Female patient, weighting 158.0 lb, was diagnosed with breast cancer  and was treated with Bevacizumab. After drug was administered, patient experienced the following side effects: alpha haemolytic streptococcal infection, atelectasis, deep vein thrombosis , dyspnoea, groin abscess, haemoglobin decreased, sepsis , ulcer . Bevacizumab dosage: 5 MG/KG, UNK. During the same period patient was treated with TRASTUZUMAB, CARBOPLATIN, PACLITAXEL, PROTONIX, WELLBUTRIN, ASPIRIN. Patient was hospitalized. Patient recovered.

Bevacizumab Side Effects Report #5547348-5
Bevacizumab side effect was reported by a Physician from UNITED STATES on Dec 03, 2007. Female patient, weighting 158.0 lb, was diagnosed with breast cancer  and was treated with Bevacizumab. After drug was administered, patient experienced the following side effects: alpha haemolytic streptococcal infection, atelectasis, blood culture positive, deep vein thrombosis , dyspnoea, groin abscess, haemoglobin decreased, perineal abscess, sepsis . Bevacizumab dosage: 5 MG/KG, UNK. During the same period patient was treated with TRASTUZUMAB, CARBOPLATIN, PACLITAXEL, PROTONIX, WELLBUTRIN, ASPIRIN. Patient was hospitalized. Patient recovered.

Bevacizumab Side Effects Report #6060935-3
Bevacizumab side effect was reported by a Pharmacist from UNITED STATES on Jan 30, 2009. Male patient, 58 years of age, weighting 238.1 lb, was diagnosed with colon cancer metastatic and was treated with Bevacizumab. After drug was administered, patient experienced the following side effects: deep vein thrombosis . Bevacizumab dosage: 523 MG ONCE IV. Patient was hospitalized. Patient recovered.

Bevacizumab Side Effects Report #5266795-2
Bevacizumab side effect was reported by a Physician from UNITED STATES on Feb 23, 2007. Female patient was treated with Bevacizumab. After drug was administered, patient experienced the following side effects: deep vein thrombosis . Bevacizumab dosage: unknown. Patient recovered.

Bevacizumab Side Effects Report #5297718-8
Bevacizumab side effect was reported by a Consumer or non-health professional from UNITED STATES on Apr 12, 2007. Female patient, weighting 171.3 lb, was treated with Bevacizumab. After drug was administered, patient experienced the following side effects: arthralgia, deep vein thrombosis , pain in extremity. Bevacizumab dosage: 1185 MG. During the same period patient was treated with FLUOROURACIL, CAMPTOSAR, LEUCOVORIN CALCIUM, ARANESP, CRESTOR, DULCOLAX, DYAZIDE, GLYBURIDE. Patient was hospitalized. Patient recovered.

Bevacizumab Side Effects Report #5302912-3
Bevacizumab side effect was reported by a Consumer or non-health professional from UNITED STATES on Apr 19, 2007. Female patient, weighting 171.3 lb, was treated with Bevacizumab. After drug was administered, patient experienced the following side effects: deep vein thrombosis . Bevacizumab dosage: 1185 MG. During the same period patient was treated with FLUOROURACIL, CAMPTOSAR, LEUCOVORIN CALCIUM, ARANESP, CRESTOR, DULCOLAX, DYAZIDE, GLYBURIDE. Patient was hospitalized. Patient recovered.


Bevacizumab Side Effects Report #5308518-4
Bevacizumab side effect was reported by a Consumer or non-health professional from UNITED STATES on Apr 24, 2007. Male patient, weighting 130.1 lb, was treated with Bevacizumab. After drug was administered, patient experienced the following side effects: deep vein thrombosis , groin pain. Bevacizumab dosage: 250 MG. During the same period patient was treated with LEUCOVORIN CALCIUM, ELOXATIN, FLUOROURACIL, MEGACE. Patient was hospitalized. Patient recovered.

Bevacizumab Side Effects Report #5400099-X
Bevacizumab side effect was reported by a Consumer or non-health professional from UNITED STATES on July 26, 2007. Male patient, weighting 215.0 lb, was treated with Bevacizumab. After drug was administered, patient experienced the following side effects: deep vein thrombosis , disease progression, lung disorder, pulmonary embolism . Bevacizumab dosage: 1956 MG. During the same period patient was treated with LEUCOVORIN CALCIUM, ELOXATIN, FLUOROURACIL, COLACE, COMPAZINE, DEXEMETHASONE, LORAZEPAM, PERCOCET. Patient was hospitalized. Patient recovered.

Bevacizumab Side Effects Report #5433847-3
Bevacizumab side effect was reported by a Consumer or non-health professional from UNITED STATES on Aug 28, 2007. Male patient, weighting 121.3 lb, was treated with Bevacizumab. After drug was administered, patient experienced the following side effects: deep vein thrombosis . Bevacizumab dosage: 1100 MG. During the same period patient was treated with FLUOROURACIL, LEUCOVORIN CALCIUM, ELOXATIN. Patient was hospitalized. Patient recovered.

Bevacizumab Side Effects Report #5441907-6
Bevacizumab side effect was reported by a Consumer or non-health professional from UNITED STATES on Aug 30, 2007. Male patient, weighting 121.3 lb, was treated with Bevacizumab. After drug was administered, patient experienced the following side effects: deep vein thrombosis , international normalised ratio abnormal. Bevacizumab dosage: 1100 MG. During the same period patient was treated with FLUOROURACIL, LEUCOVORIN CALCIUM, ELOXATIN. Patient was hospitalized. Patient recovered.

Bevacizumab Side Effects Report #5447366-1
Bevacizumab side effect was reported by a Consumer or non-health professional from UNITED STATES on Sept 05, 2007. Male patient, weighting 121.3 lb, was treated with Bevacizumab. After drug was administered, patient experienced the following side effects: deep vein thrombosis , international normalised ratio decreased, pulmonary embolism . Bevacizumab dosage: 1100 MG. During the same period patient was treated with LEUCOVORIN CALCIUM, ELOXATIN, FLUOROURACIL. Patient was hospitalized. Patient recovered.

Bevacizumab Side Effects Report #5467081-8
Bevacizumab side effect was reported by a Consumer or non-health professional from UNITED STATES on Sept 21, 2007. Male patient, weighting 121.3 lb, was treated with Bevacizumab. After drug was administered, patient experienced the following side effects: deep vein thrombosis , international normalised ratio decreased, pulmonary embolism . Bevacizumab dosage: 1100 MG. Patient was hospitalized. Patient recovered.

Bevacizumab Side Effects Report #6100280-0
Bevacizumab side effect was reported by a Health Professional from UNITED STATES on Feb 25, 2009. Male patient, weighting 134.0 lb, was diagnosed with colorectal cancer  and was treated with Bevacizumab. After drug was administered, patient experienced the following side effects: anaemia, deep vein thrombosis , gastrointestinal haemorrhage, international normalised ratio increased, oesophagitis, prothrombin time prolonged, shock haemorrhagic. Bevacizumab dosage: 5 MG/KG, Q2W. During the same period patient was treated with OXALIPLATIN, FLUOROURACIL, LEUCOVORIN CALCIUM, ZOFRAN, PRILOSEC, ALTERNAGEL, LASIX. Patient was hospitalized. Patient died on 04/27/2008.